Randomized trial · people

Pramlintide-insulin mix: 2.1 kg more weight loss than lispro

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In type 1 diabetes, taking pramlintide together with mealtime insulin in one shot led to modest weight loss and lower mealtime insulin needs over 16 weeks, with more gut symptoms but no clear rise in low blood sugar.

Kind
Randomized trial
Studied in
People
Number studied
80
Published
2024
Journal
Diabetes Obes Metab

What they tested

The team tested whether ADO09, a single shot that mixes pramlintide with insulin A21G, changes body weight, blood sugar control and safety compared with insulin lispro in people with type 1 diabetes.

How the study was done

A randomized trial in 80 people with type 1 diabetes, who went about their normal lives during the study. For 16 weeks they took either ADO09 or insulin lispro as their mealtime insulin.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking pramlintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Weight loss was the main outcome. People on ADO09 kept losing weight and lost 2.1 kg relative to those on lispro. Blood sugar control was fairly good in both groups, with a mean HbA1c (glycated hemoglobin, a longer-term average of blood sugar) of 7.7%, and it did not change during the study. The ADO09 group used 21% less mealtime insulin while their basal (background) insulin dose stayed the same, and stomach and gut symptoms were more common with ADO09, with no clear difference in low blood sugar episodes.

What it doesn’t show

This was a short 16-week trial with 80 people. It tested pramlintide only as part of a mixed product with insulin A21G, so it does not show the effect of pramlintide on its own.

The paper

Andersen et al. ADO09, a co-formulation of pramlintide and insulin A21G, lowers body weight versus insulin lispro in type 1 diabetes. Diabetes Obes Metab. 2024.

The compound

More studies on Pramlintide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking pramlintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo